Spesana Launches Advisory Board to Support Company Growth

Following a successful presentation and exhibit at this year’s Precision Medicine World Conference, a new advisory board is formed to support Spesana’s mission.

MEMPHIS, Tenn.--(BUSINESS WIRE)--Spesana has announced the formation of the Spesana Advisory Board with appointments of experienced industry leaders across clinical sites, life science companies and diagnostic labs. The Advisory Board will collaborate on strategy for multiple healthcare stakeholders' use of the Spesana Healthcare Platform in clinical, operational, and financial workflows advancing precision medicine.

“It takes visionary, passionate experts to move healthcare in the right direction. The Advisors are key to realizing the vision and mission of Spesana as an overarching healthcare platform to serve all therapeutic areas, geographies and healthcare stakeholders across clinical sites, molecular diagnostic labs, pharma and revenue cycle. I’m grateful these advisors bring their expertise to the biggest healthtech challenge of the last 25 years,” said Carla Balch CEO of Spesana.

Members of the Advisory Board include innovative leaders with a passion to drive precision medicine:

DR. JEFFERY EDENFIELD

Dr. Edenfield is board certified in Medical Oncology, Hematology and Internal Medicine serving as the medical director for the Institute for Translational Oncology Research of phase I and first-in-human clinical trials and management of the Biorepository Services at GHS. He advised Spesana before its incorporation.

MICHELE CHULICK

Michele has deep expertise in the clinical setting having served as President/CEO of Wyoming Medical Center; EVP and Chief Administrative Officer of Children’s Health System of Texas, while also serving as President of Children’s Health system of Texas Ventures.

BRETT MCCLUNG

Brett is an innovation expert evidenced by his selection by Stanford Distinguished Careers Institute 2022 Cohort: One of 30 executive professionals chosen for fellowship at Stanford University. He served as President/CEO of Baptist Health in Jacksonville, FL, and EVP of Texas Health Resources, one of the largest faith-based, nonprofit health care systems in the USA.

PAUL OWEN

Paul is President and Interim CEO for imaware, a digital health platform that offers advanced at-home lab tests that empower individuals, providers, employers, providing essential preventative healthcare services for cardiovascular disease, prostate cancer, and autoimmune disorders.

BOBBI COFFIN

Bobbi is a strategic rainmaker having served as Chief Growth Officer, Chief Marketing Officer at Biodesix, a multiple product lab company in precision medicine. Her knowledge of the precision medicine space includes executive roles at Exact Sciences and Precision Therapeutics.

AUTRI DUTTA

Autri is a scientist having served executive positions at Roche and Philips as Head of Strategic Marketing, Operations and Genomics, Head of Business Development and Oncology Informatics, VP and Life Cycle Leader of Sequencing Informatics, Autri is successful at growing organizations through operational management, commercial execution through deep, collaborative relationships.

About Spesana

Spesana has developed a healthcare platform for all therapeutic areas in all settings of care to increase the velocity of patients moving to the right specialists with a unified medical record. Important to the mission is the focus on precision medicine, notably molecular diagnostics, and clinical collaborations to allow physicians, patients, and insurance teams to come together around the best available therapies and new clinical trials for patients. The company was founded by oncology information technology trailblazer Carla Balch and an experienced team known for building the first certified electronic medical record platform in oncology. Spesana creates real-time collaborations, decision support based on real-world data and molecular diagnostics results.

LinkedIn: spesanaco | www.spesana.com